How to taper off metoprolol (beta blocker) and initiate an Angiotensin-Converting Enzyme (ACE) inhibitor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Transitioning from metoprolol to an ACE inhibitor should be done gradually under medical supervision, starting by reducing metoprolol dose by 25-50% every 1-2 weeks while monitoring blood pressure and heart rate, and then initiating a low dose of an ACE inhibitor such as lisinopril 2.5-5mg daily or enalapril 2.5mg daily, with gradual dose increases every 1-2 weeks as metoprolol is further reduced, as recommended by the most recent guidelines 1.

Key Considerations

  • The transition process should prioritize monitoring for side effects, including dizziness, cough, or changes in kidney function, to prevent rebound hypertension or worsening of underlying heart conditions that can occur with abrupt beta-blocker discontinuation.
  • The choice of ACE inhibitor and its initial dose should be based on the patient's specific condition and the guidelines provided by recent studies, such as those outlined in the European Society of Cardiology guidelines 1.
  • It is crucial to check renal function and electrolytes before starting the ACE inhibitor and to re-check blood chemistry 1–2 weeks after initiation and 1–2 weeks after final dose titration, as advised in the guidelines 1.

Monitoring and Dose Adjustment

  • Blood pressure, renal function, and electrolytes should be monitored closely during the transition period, with adjustments made as necessary to prevent adverse effects.
  • The dose of the ACE inhibitor should be doubled at not less than 2-week intervals in the community, or more rapidly in a hospital setting with close monitoring, tolerability permitting, as recommended by the guidelines 1.
  • The goal is to aim for the target dose or the highest tolerated dose, remembering that some ACE inhibitor is better than none, as emphasized in the guidelines 1.

Patient Education and Follow-Up

  • A specialist HF nurse may assist with patient education, follow-up, biochemical monitoring, and dose up-titration to ensure a smooth transition and optimal patient outcomes.
  • Patients should be instructed to contact their doctor immediately if they experience chest pain, severe dizziness, significant blood pressure changes, or worsening symptoms during the transition, highlighting the importance of close medical supervision throughout this process.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.